 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Nexell Therapeutics Inc.
 |
Nexell Therapeutics Inc. |
 |
 |
 |
PROFILE |
 |
Nexell Therapeutics looks for the secrets contained in cells. Its principal subsidiary, Nexell of California, makes cell selection technology used to research and develop treatments for cancer and other diseases. Nexell products include specialized instruments, sterile plastics sets, and the Isolex Cell Selection system. Offered in five different versions (one is available only in Europe), the Isolex system is used to separate cells from blood and bone marrow. Most of Nexell's sales are in the US, but it also markets its products in Europe and Canada. Leading medical supply maker and former Nexell distributor Baxter International owns almost 40% of the company.
COMPETITION |
 |
Aastrom Biosciences, Inc. (ASTM)
Beckman Coulter, Inc. (BEC)
Becton, Dickinson and Company (BDX)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 18.20
1-Yr. Sales Growth: 21.3%
Employees: 105
Revenue per employee: $173,333.33
KEY PEOPLE |
 |
William A. Albright
CEO
William A. Albright
CFO
CONTACT INFO |
 |
9 Parker
Irvine, CA 92618
US
Phone: 949-470-9011
Fax: 949-586-2420
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |